This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Transducin
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 8: | Line 8: | ||
== Disease == | == Disease == | ||
Congenital stationary night blindness (Nougaret disease) is caused by a mutation in TDN α subunit<ref>PMID:8673138</ref>. | Congenital stationary night blindness (Nougaret disease) is caused by a mutation in TDN α subunit<ref>PMID:8673138</ref>. | ||
| + | |||
==3D structures of transducin== | ==3D structures of transducin== | ||
[[Transducin 3D structures]] | [[Transducin 3D structures]] | ||
| Line 13: | Line 14: | ||
</StructureSection> | </StructureSection> | ||
| - | ==3D structures of transducin== | ||
| - | |||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *Transducin-α | ||
| - | |||
| - | **[[1tnd]] – bTDN + GTPγS - bovine<br /> | ||
| - | **[[1tag]] – bTDN + GDP<br /> | ||
| - | **[[3v00]] – b/ratTDN + GDP<br /> | ||
| - | **[[1tad]] – bTDN + GDP + AlF4<br /> | ||
| - | **[[1fqk]] – bTDN + RGS9 + GDP + AlF4<br /> | ||
| - | **[[1fqj]] – bTDN + RGS9 + GMP-PDE γ + GDP + AlF4<br /> | ||
| - | |||
| - | *Transducin-β | ||
| - | |||
| - | **[[6n9g]] – TDN + RGS7 - mouse<br /> | ||
| - | |||
| - | *Transducin-βγ | ||
| - | |||
| - | **[[5he0]], [[5he1]], [[5he2]], [[5he3]], [[5ukk]], [[5ukl]], [[5ukm]] – hTDN + β-adrenergic receptor kinase 1 + inhibitor<br /> | ||
| - | **[[4kfm]] – hTDN + G-protein activated inward rectifier K+ channel<br /> | ||
| - | **[[6m8s]] – hTDN + KCTD12<br /> | ||
| - | **[[6nbi]], [[6nbh]], [[6nbf]] – hTDN + PTH/PTHRP + long-acting parathyroid hormone + GS protein a subunit + nanobody – Cryo EM<br /> | ||
| - | **[[4pnk]] – h/bTDN + bγ (mutant)+ β-adrenergic receptor kinase 1 + inhibitor<br /> | ||
| - | **[[1tbg]] – bTDN <br /> | ||
| - | **[[2trc]], [[1a0r]], [[1b9x]], [[1b9y]] – bTDN + phosducin<br /> | ||
| - | **[[1omw]], [[3cik]] – bTDN + G-protein coupled receptor kinase 2<br /> | ||
| - | **[[3v5w]] – bTDN (mutant) + G-protein coupled receptor kinase 2<br /> | ||
| - | **[[3psc]], [[3pvu]], [[3pvw]], [[4mk0]] – bTDN + β-adrenergic receptor kinase 1<br /> | ||
| - | **[[2bcj]] – bTDN (mutant) + β-adrenergic receptor kinase 1<br /> | ||
| - | **[[3uzs]] – bTDN + β-adrenergic receptor kinase 1 + RNA<br /> | ||
| - | **[[3krw]], [[3krx]], [[6c2y]], [[5wg5]], [[5wg4]], [[5wg3]] – bTDN + G-protein coupled receptor kinase 2 + inhibitor<br /> | ||
| - | **[[1xhm]] – bTDN + peptide<br /> | ||
| - | **[[6pcv]] – bTDN + RAC exchanger – Cryo EM<br /> | ||
| - | **[[6b20]] – bTDN + nanobody<br /> | ||
| - | |||
| - | *Transducin-α+βγ | ||
| - | |||
| - | **[[6eg8]] – hTDN + GDP<br /> | ||
| - | **[[6ddf]], [[6dde]] – hTDN + mu opioid receptor + DAMGO – Cryo EM<br /> | ||
| - | **[[6d9h]] – hTDN + AChR/adenosine receptor – Cryo EM<br /> | ||
| - | **[[6p9x]] – hTDN + CRFR-1 + corticliberin – Cryo EM<br /> | ||
| - | **[[6osa]] – hTDN + NTR1 + JMV449 – Cryo EM<br /> | ||
| - | **[[6g79]] – hTDN + serotonin receptor – Cryo EM<br /> | ||
| - | **[[6oy9]] – bTDN + rhodopsin + retinal – Cryo EM<br /> | ||
| - | **[[6oya]] – bTDN + antibody + rhodopsin + retinal – Cryo EM<br /> | ||
| - | **[[1got]] – bTDN + GDP<br /> | ||
| - | **[[1gp2]], [[5kdo]], [[1gg2]] – r/bTDN + GDP - rat<br /> | ||
| - | **[[3ah8]] – r/bTDN (mutant) + GDP + inhibitor<br /> | ||
| - | **[[5tdh]] – h/r/bTDN (mutant) + GDP<br /> | ||
| - | |||
| - | *Transducin-α+βγ complex with antibody | ||
| - | |||
| - | **[[6pt0]], [[6n4b]], [[6kpg]], [[6kpf]] – hTDN + cannaboid receptor + antibody fragment – Cryo EM<br /> | ||
| - | **[[6pb1]], [[6pb0]] – hTDN + CRFR-2 + urocortin + nanobody – Cryo EM<br /> | ||
| - | **[[6os9]] – hTDN + NTR1 + JMV449 + antibody fragment – Cryo EM<br /> | ||
| - | **[[6oik]], [[6oij]] – hTDN + AChR + antibody fragment – Cryo EM<br /> | ||
| - | **[[6crk]] – hTDN + antibody fragment <br /> | ||
| - | **[[6niy]], [[6e3y]] – hTDN + calcitonin receptor + calcitonin + nanobody – Cryo EM<br /> | ||
| - | **[[5uz7]] – hTDN + calcitonin receptor + antibody fragment - Cryo EM<br /> | ||
| - | **[[6ni3]] – hTDN + endolysin/adrenergic receptor + nanobody – Cryo EM<br /> | ||
| - | **[[6omm]] – hTDN + formyl peptide receptor + peptide agonist + antibody fragment – Cryo EM<br /> | ||
| - | **[[6p9y]] – hTDN + PACAP + nanobody – Cryo EM<br /> | ||
| - | **[[6li3]] – hTDN + GPR52 + nanobody – Cryo EM<br /> | ||
| - | **[[6gdg]] – hTDN + adenosine A2A receptor + nanobody – Cryo EM<br /> | ||
| - | **[[6b3j]] – hTDN + GLP-1R + exendin-p5 + nanobody – Cryo EM<br /> | ||
| - | **[[6ot0]] – hTDN + antibody + smoothened homolog – Cryo EM<br /> | ||
| - | **[[6cmo]] – hTDN + antibody + rhodopsin/cytochrome b562 – Cryo EM<br /> | ||
| - | **[[6qno]] – h/bTDN + antibody + rhodopsin + retinal – Cryo EM<br /> | ||
| - | **[[5vai]] – h/r/bTDN + glucagon-like peptide + antibody fragment - Cryo EM<br /> | ||
| - | **[[3sn6]] – TDN ba (mutant) + rb (mutant) + bc + endolysine + antibody fragment<br /> | ||
| - | |||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Current revision
| |||||||||||
References
- ↑ Lerea CL, Bunt-Milam AH, Hurley JB. Alpha transducin is present in blue-, green-, and red-sensitive cone photoreceptors in the human retina. Neuron. 1989 Sep;3(3):367-76. PMID:2534964
- ↑ Dryja TP, Hahn LB, Reboul T, Arnaud B. Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet. 1996 Jul;13(3):358-60. PMID:8673138 doi:http://dx.doi.org/10.1038/ng0796-358
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman

